| 1 | Risankizumab | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0374件: 37, 96, 97, 271 💬 | 
| 2 | Risankizumab (genetical recombination) | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0971件: 97 💬 | 
| 3 | Risankizumab 10 mg/ml | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0961件: 96 💬 | 
| 4 | Risankizumab 180 mg sc | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0961件: 96 💬 | 
| 5 | Risankizumab 600 mg iv | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0961件: 96 💬 | 
| 6 | Risankizumab 90 mg/ml | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0961件: 96 💬 | 
| 7 | Risankizumab iv | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0962件: 96, 97 💬 | 
| 8 | Risankizumab sc | Risankizumab | 1件: D11052D11052 💬 | IL23A1件: IL23A 💬 | C-type lectin receptor signaling pathway9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis | 0962件: 96, 97 💬 |